IN188917B - - Google Patents

Info

Publication number
IN188917B
IN188917B IN1106MU2000A IN188917B IN 188917 B IN188917 B IN 188917B IN 1106MU2000 A IN1106MU2000 A IN 1106MU2000A IN 188917 B IN188917 B IN 188917B
Authority
IN
India
Application number
Other languages
English (en)
Inventor
Srikanth Annappa Pai
Sangeeta Hanurmesh Rivankar
Shilpa Sudhakar Kocharekar
Original Assignee
Bharat Surums & Vaccines Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bharat Surums & Vaccines Ltd filed Critical Bharat Surums & Vaccines Ltd
Priority to IN1106MU2000 priority Critical patent/IN188917B/en
Priority to AT01999369T priority patent/ATE279917T1/de
Priority to DE60106647T priority patent/DE60106647T2/de
Priority to US10/250,420 priority patent/US20040235964A1/en
Priority to HK04107880.4A priority patent/HK1064954B/xx
Priority to MXPA03006054 priority patent/MX228228B/es
Priority to AU2002217418A priority patent/AU2002217418A1/en
Priority to ES01999369T priority patent/ES2231583T3/es
Priority to CNB018225349A priority patent/CN1283235C/zh
Priority to PCT/IN2001/000213 priority patent/WO2002045709A1/en
Priority to CA002432549A priority patent/CA2432549A1/en
Priority to EP01999369A priority patent/EP1351669B1/en
Priority to RU2003119556/15A priority patent/RU2257892C2/ru
Publication of IN188917B publication Critical patent/IN188917B/en
Priority to ZA200304981A priority patent/ZA200304981B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A61P23/02—Local anaesthetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Anesthesiology (AREA)
  • Dermatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Chemical And Physical Treatments For Wood And The Like (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
IN1106MU2000 2000-12-07 2000-12-07 IN188917B (en:Method)

Priority Applications (14)

Application Number Priority Date Filing Date Title
IN1106MU2000 IN188917B (en:Method) 2000-12-07 2000-12-07
ES01999369T ES2231583T3 (es) 2000-12-07 2001-12-05 Composiciones transparentes de propofol.
CNB018225349A CN1283235C (zh) 2000-12-07 2001-12-05 清澈稳定的丙泊酚组合物
US10/250,420 US20040235964A1 (en) 2000-12-07 2001-12-05 Clear propofol compositions
HK04107880.4A HK1064954B (en) 2000-12-07 2001-12-05 Clear propofol compositions
MXPA03006054 MX228228B (es) 2000-12-07 2001-12-05 Composiciones de propofol claras, estables.
AU2002217418A AU2002217418A1 (en) 2000-12-07 2001-12-05 Clear propofol compositions
AT01999369T ATE279917T1 (de) 2000-12-07 2001-12-05 Klare propofolzusammensetzungen
DE60106647T DE60106647T2 (de) 2000-12-07 2001-12-05 Klare propofolzusammensetzungen
PCT/IN2001/000213 WO2002045709A1 (en) 2000-12-07 2001-12-05 Clear propofol compositions
CA002432549A CA2432549A1 (en) 2000-12-07 2001-12-05 Clear propofol compositions
EP01999369A EP1351669B1 (en) 2000-12-07 2001-12-05 Clear propofol compositions
RU2003119556/15A RU2257892C2 (ru) 2000-12-07 2001-12-05 Прозрачные стабильные композиции пропофола
ZA200304981A ZA200304981B (en) 2000-12-07 2003-06-26 Clear propofol compositions.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN1106MU2000 IN188917B (en:Method) 2000-12-07 2000-12-07

Publications (1)

Publication Number Publication Date
IN188917B true IN188917B (en:Method) 2002-11-23

Family

ID=11097320

Family Applications (1)

Application Number Title Priority Date Filing Date
IN1106MU2000 IN188917B (en:Method) 2000-12-07 2000-12-07

Country Status (13)

Country Link
US (1) US20040235964A1 (en:Method)
EP (1) EP1351669B1 (en:Method)
CN (1) CN1283235C (en:Method)
AT (1) ATE279917T1 (en:Method)
AU (1) AU2002217418A1 (en:Method)
CA (1) CA2432549A1 (en:Method)
DE (1) DE60106647T2 (en:Method)
ES (1) ES2231583T3 (en:Method)
IN (1) IN188917B (en:Method)
MX (1) MX228228B (en:Method)
RU (1) RU2257892C2 (en:Method)
WO (1) WO2002045709A1 (en:Method)
ZA (1) ZA200304981B (en:Method)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6939564B2 (en) 2001-06-08 2005-09-06 Labopharm, Inc. Water-soluble stabilized self-assembled polyelectrolytes
NZ538255A (en) 2002-07-29 2006-11-30 Transform Pharmaceuticals Inc Aqueous 2,6-diisopropylphenol pharmaceutical compositions
US7550155B2 (en) 2002-07-29 2009-06-23 Transform Pharmaceuticals Inc. Aqueous pharmaceutical compositions of 2,6-diisopropylphenol (propofol) and their uses
US8476010B2 (en) * 2003-07-10 2013-07-02 App Pharmaceuticals Llc Propofol formulations with non-reactive container closures
BRPI0506812B8 (pt) 2004-02-13 2021-05-25 Bioavailability Inc composição base anidra auto-microemulsificável, microemulsão e método de preparação da composição base automicroemulsificável
KR20070058608A (ko) * 2004-09-13 2007-06-08 바라트 쎄럼스 앤드 백신스 리미티드 항미생물 방부 효능을 갖는 정맥 내 투여를 위한 안정한에멀젼 조성물
US20060198891A1 (en) 2004-11-29 2006-09-07 Francois Ravenelle Solid formulations of liquid biologically active agents
US20060210498A1 (en) * 2005-03-18 2006-09-21 Unilever Home & Personal Care Usa, Division Of Conopco, Inc. Novel resorcinol derivatives for skin
BRPI0604377A (pt) * 2006-10-27 2008-06-24 Cristalia Prod Quimicos Farm microemulsão óleo/água de propofol estável e pronta-para-uso
EP2548456B1 (en) 2008-03-20 2015-07-08 Virun, Inc. Emulsions including a PEG-derivative of tocopherol
AT514764A1 (de) * 2013-09-02 2015-03-15 Sanochemia Ag Beta-Carotin Zubereitung
US11266621B1 (en) 2014-10-02 2022-03-08 Exela Sterile Medicines Llc Methocarbamol composition and related methods
CN108601732A (zh) * 2015-12-09 2018-09-28 磷肌酸有限公司 药物制剂
KR102647670B1 (ko) 2016-12-21 2024-03-15 아베초 바이오테크놀로지 리미티드 방법
CN114601800B (zh) * 2021-09-28 2023-07-28 天津瑞普生物技术股份有限公司 一种甲磷丙泊酚钠无菌粉针剂及其制备方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9405593D0 (en) * 1994-03-22 1994-05-11 Zeneca Ltd Pharmaceutical compositions
US6458373B1 (en) * 1997-01-07 2002-10-01 Sonus Pharmaceuticals, Inc. Emulsion vehicle for poorly soluble drugs
EP1052975B1 (en) * 1998-02-10 2007-08-22 Sicor Inc. Propofol composition containing sulfite
ATE283042T1 (de) * 1999-01-28 2004-12-15 Dinesh Shantilal Patel Parenterale lösungen enthaltend propofol (2,6- diisopropylphenol) und 2.5-di-0-methyl-1.4;3.6- dianhydro-d-glucitol als lösungsmittel
CA2377614C (en) * 1999-06-21 2008-07-29 Kuhnil Pharm. Co., Ltd. Anesthetic composition for intravenous injection comprising propofol
IN187686B (en:Method) * 2000-06-21 2002-06-08 Bharat Serums & Vaccines Ltd
AU2002239282A1 (en) * 2000-11-28 2002-06-11 Transform Pharmaceuticals, Inc. Pharmaceutical formulations comprising paclitaxel, derivatives, and pharmaceutically acceptable salts thereof

Also Published As

Publication number Publication date
ES2231583T3 (es) 2005-05-16
WO2002045709A1 (en) 2002-06-13
DE60106647D1 (de) 2004-11-25
ZA200304981B (en) 2004-04-23
DE60106647T2 (de) 2005-11-10
HK1064954A1 (en) 2005-02-08
AU2002217418A1 (en) 2002-06-18
CN1489457A (zh) 2004-04-14
ATE279917T1 (de) 2004-11-15
EP1351669A1 (en) 2003-10-15
MX228228B (es) 2005-06-01
RU2257892C2 (ru) 2005-08-10
CN1283235C (zh) 2006-11-08
US20040235964A1 (en) 2004-11-25
CA2432549A1 (en) 2002-06-13
EP1351669B1 (en) 2004-10-20
MXPA03006054A (es) 2003-09-10

Similar Documents

Publication Publication Date Title
BE2015C062I2 (en:Method)
BE2013C060I2 (en:Method)
BE2012C016I2 (en:Method)
JP2003504141A5 (en:Method)
BE2011C032I2 (en:Method)
BE2011C041I2 (en:Method)
JP2003514798A5 (en:Method)
IN2003KO00001A (en:Method)
JP2002010208A5 (en:Method)
JP2002543372A5 (en:Method)
AR028236A3 (en:Method)
JP2001328553A5 (en:Method)
JP2001281476A5 (en:Method)
IN192750B (en:Method)
JP2001176034A5 (en:Method)
IN188917B (en:Method)
JP2001194611A5 (en:Method)
JP2001269483A5 (en:Method)
JP2002089399A5 (en:Method)
JP2001257833A5 (en:Method)
JP2002028387A5 (en:Method)
JP2000310635A5 (en:Method)
JP2001195086A5 (en:Method)
JP2001217795A5 (en:Method)
JP2001295339A5 (en:Method)